Corteva, IncNYSE: CTVA
Materials · Fertilizers & Agricultural Chemicals
$78.58
+2.22%
Vol: 196K
Research Digest
Wednesday, June 17, 2026
No significant overnight updates
No material news in the last 48 hours.
Previous Market Intelligence
13 daysJun 16Corteva draws fresh bullish analyst targets in mid-June as multiple firms raise price targets ahead of its planned Q4 2026 separation.Positive▶
In mid-June 2026, Corteva attracted a cluster of analyst actions: Barclays' Benjamin Theurer raised his target to $91 from $84 (Overweight) and Morgan Stanley's Vincent Andrews lifted his to $95 from $84 (Overweight), while UBS's Joshua Spector trimmed his to $86 from $90 (Neutral). The renewed attention comes alongside Corteva's $0.18 quarterly dividend payable June 15, 2026, and its progress toward splitting into two companies in Q4 2026 — a crop-protection business ("New Corteva," headquartered in Indianapolis) and a seed and genetics business ("Vylor," headquartered in Johnston, Iowa). Q1 2026 net sales were $4.9 billion, up 11% year-over-year, supporting the bullish case built on product development, pricing discipline, and the separation unlocking value. The bear case, reflected in the UBS cut, centers on rising input costs, trade-related uncertainty, and execution risk on the complex separation. Q2 2026 earnings are due July 30.
Jun 15No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Jun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Corteva confirmed Indianapolis and Iowa HQs for its two post-separation companies and reaffirmed Q4 2026 split timeline.Positive▶
On May 12, 2026, Corteva announced that 'New Corteva' (crop protection) will be headquartered in Indianapolis, Indiana, while its seed and genetics spinoff Vylor will be based in Johnston, Iowa. The separation remains on track for Q4 2026. Q1 2026 results posted May 5 showed 11% net sales growth, 7% organic growth, 21% EBITDA growth, and EPS of $1.50 versus $1.17 consensus. CEO Chuck Magro told the BMO Farm to Market conference on May 14 there were 'no showstoppers' for the spin. UBS raised PT to $90 (Neutral) and Citi raised PT to $85 (Neutral).
May 20No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 19Corteva names Indianapolis and Johnston as future-company HQs and brands seed spinoff as Vylor; Q4 2026 separation on track.Positive▶
Corteva announced May 12 that 'New Corteva' (crop protection) will be HQ'd in Indianapolis and the spinoff branded Vylor (advanced seed and genetics) will be HQ'd in Johnston, Iowa, with the separation targeted for Q4 2026. Q1 2026 net sales rose 11% YoY (+7% organic) and EPS of $1.50 beat $1.174 consensus; FY26 outlook reaffirmed. CEO Magro and CFO Johnson presented at the BMO Farm to Market conference May 14. Capital World disclosed a 5.5% stake (May 13). Risk: pricing pressure in ag markets and execution risk on the spin.
May 18Corteva named Indianapolis and Iowa as future HQs for its post-separation companies on May 12, with CEO Magro presenting at BMO Farm to Market on May 14.Positive▶
On May 12, 2026, Corteva announced headquarters for the two future companies after its planned Q4 2026 separation: "New Corteva" (crop protection) in Indianapolis, Indiana, and Vylor (advanced seed and genetics) in Johnston, Iowa. On May 14, CEO Chuck Magro and CFO David Johnson presented at the BMO Global Farm to Market Conference. These follow strong Q1 2026 results (net sales +11%, organic sales +7%, Operating EBITDA $1.44B, Operating EPS $1.50) and reaffirmed FY26 guidance ($4.0-$4.2B EBITDA, $3.45-$3.70 EPS). Analyst targets were raised: RBC to $95, Oppenheimer to $89, Wells Fargo to $90; consensus 12-month target lifted to $89.6 (16 Buys, 9 Holds).
May 15Corteva CEO and CFO present at BMO Farm-to-Market conference May 14 as Q4 separation into New Corteva and Vylor stays on track.Positive▶
CEO Chuck Magro and CFO David Johnson presented at the BMO Global Farm to Market conference on May 14, 2026. The company reaffirmed full-year 2026 guidance with Operating EBITDA of $4.0-4.2 billion and Operating EPS of $3.45-3.70. Corteva is on track for a Q4 2026 corporate separation: the crop protection company (New Corteva) will be headquartered in Indianapolis, Indiana, while the seed and genetics spinoff (Vylor) will be based in Johnston, Iowa. Q1 2026 net sales rose 11% to $4.9 billion with organic sales up 7% and operating EBITDA up 21%. Recent analyst price target increases include UBS ($90), Bank of America ($90), and Citi ($85). Sentiment is positive given strong execution and clarifying separation milestones.
May 14Corteva names seed spinoff Vylor and confirms HQs in Indianapolis and Iowa as 4Q 2026 separation stays on track; CEO at BMO conference todayPositive▶
Corteva announced its advanced seed and genetics SpinCo will be branded Vylor, Inc., headquartered in Johnston, Iowa, while New Corteva (crop protection) will be headquartered in Indianapolis, Indiana. The separation remains on track for Q4 2026. Vylor will be anchored by more than 4,000 germplasm patents and more than 2,000 biotechnology patents, with a pipeline including proprietary hybrid wheat, gene editing, multi-disease resistance corn, and next-generation biofuels. Q1 2026 sales rose 11% YoY with organic sales up 7% and operating EPS of $1.50 beating $1.18 consensus by 27%. The company reaffirmed FY2026 guidance of $4.0-$4.2B operating EBITDA and operating EPS of $3.45-$3.70. CEO Chuck Magro and CFO David Johnson are speaking at the BMO Global Farm to Market conference today (May 14) at 11:00 a.m. EDT. CTVA declared a $0.18 dividend with ex-date June 1. BofA recently raised its price target. Analyst consensus is Buy with average PT of $84.13.
May 13Corteva announces Indianapolis and Iowa as headquarters for two future companies following planned Q4 2026 separationPositive▶
On May 12, 2026, Corteva announced that 'New Corteva,' its future crop protection company, will be headquartered in Indianapolis, Indiana, while Vylor, its advanced seed and genetics spinoff, will be headquartered in Johnston, Iowa. New Corteva's Global Corporate Business Center will be in Wilmington, Delaware, and Vylor's in Southeast Pennsylvania. This follows the planned separation in Q4 2026. Corteva also previously announced Luke Kissam as New Corteva CEO. The company recently reaffirmed full-year 2026 guidance with operating EBITDA of $4.0-$4.2 billion. Analyst price targets have been raised by UBS, BofA, and Citi following strong Q1 results.
May 12Corteva named seed-business spinoff Vylor with Q4 2026 separation on track, after Q1 sales rose 11% to $4.9B and analysts hiked price targetsPositive▶
Corteva announced on May 4, 2026 that its planned seed-and-genetics spinoff will be branded Vylor, Inc., with the separation on track for Q4 2026; Vylor carries 4,000+ germplasm patents and 2,000+ biotech patents. Q1 2026 net sales rose 11% YoY to $4.9B with operating EBITDA of $1.44B and EPS of $1.50, reaffirming full-year guidance of $4.0-$4.2B EBITDA and $3.45-$3.70 EPS. The company plans $500M in buybacks and declared a $0.18 quarterly dividend. Multiple analysts raised targets following the print: UBS to $90 from $88, Bank of America to $90 from $87, Citi to $85 from $83. CEO Chuck Magro and CFO David Johnson will present at BMO's Global Farm to Market conference on May 14.
May 11Corteva delivers Q1 beat with 11% sales growth and unveils Vylor as new spin-off seed business namePositive▶
Corteva reported Q1 2026 net sales of $4.9 billion, up 11% year-over-year (organic up 7%), with Operating EBITDA of $1.44 billion and Operating EPS of $1.50. The company reaffirmed full-year 2026 guidance of $4.0-$4.2B Operating EBITDA and $3.45-$3.70 Operating EPS and remains on track for a Q4 2026 corporate separation into two entities. The advanced seed and genetics business previously called "SpinCo" will be branded Vylor, Inc. The company declared a $0.18 quarterly dividend. UBS raised its price target to $90 from $88. CEO Chuck Magro and CFO David Johnson will present at the BMO Global Farm to Market conference on May 14.
May 8Corteva crushes Q1 estimates with $1.50 EPS (+$0.32 beat) and narrows Vylor spinoff timelinePositive▶
Corteva reported Q1 2026 EPS of $1.50 (beat $1.18 estimate by $0.32) with revenue of $4.91B vs. $4.64B expected. 21% EBITDA growth demonstrates pricing power. Company introduced Vylor brand for advanced seed/genetics spinoff and remains on track for Q4 2026 separation, with trending favorably against $100M net dis-synergy estimate. FY26 guidance reaffirmed: Operating EBITDA $4.0-4.2B, Operating EPS $3.45-3.70, with ~$500M H1 2026 share repurchase planned. 16 analysts rate Buy with $84.13 target (+4.06%).
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CTVACORTEVA | $78.58 | +2.22% | -5.2% | 18.7x | 0.57 | $51.4B |
| CFCF | $105.56 | -0.03% | -15.7% | 9.2x | 0.38 | $16.2B |
| MOSMOSAIC | $22.28 | +2.72% | +1.3% | 11.8x | 0.81 | $6.9B |
| LINLINDE | $513.81 | -0.84% | +1.4% | 26.3x | 0.73 | $239.6B |
| NEMNEWMONT | $108.35 | -0.08% | -1.3% | 9.5x | 0.46 | $115.8B |
| FCXFREEPORT | $70.45 | +0.43% | +15.9% | 18.0x | 1.36 | $100.8B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price between 50d and 200d. Testing 50d support.